Most Recent

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: Some Human Cancers Exhibit Low-grade Inflammation

Some Human Cancers Exhibit Low-grade Inflammation

By | October 1, 2016

NSAIDs reduce this "parainflammation," hinting at how they help lower cancer risk.

0 Comments

image: Gene Editing: From Roots to Riches

Gene Editing: From Roots to Riches

By | October 1, 2016

Advances in genetic manipulation have simplified the once daunting task of rewriting a gene.

2 Comments

image: Scientists Catch Translation in the Act

Scientists Catch Translation in the Act

By | October 1, 2016

Newly developed techniques from four different groups rely on the same basic steps to track translation in live cells.

0 Comments

image: Stem Cells Made Waves in Biology and Medicine

Stem Cells Made Waves in Biology and Medicine

By | October 1, 2016

Since their introduction to the lab, pluripotent stem cells have gone from research tool to therapeutic, but the journey has been rocky.

0 Comments

image: Thirty Years of Progress

Thirty Years of Progress

By | October 1, 2016

Since The Scientist published its first issue in October 1986, life-science research has transformed from a manual and often tedious task to a high-tech, largely automated process of unprecedented efficiency.

1 Comment

image: Circadian-Controlled Thirst

Circadian-Controlled Thirst

By | September 28, 2016

Scientists determine how the brain’s central clock regulates drinking prior to sleep in rodents.

1 Comment

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Facebook CEO’s Donation a Boon to Basic Science

Facebook CEO’s Donation a Boon to Basic Science

By | September 25, 2016

But can $3 billion dollars meet the lofty goals of the Chan Zuckerberg Initiative?

1 Comment

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Inflammation Drives Gut Bacteria Evolution
  4. Women Lose Vision After Stem Cell Treatment
Business Birmingham